Publications by Yu Li Su

Publications by authors named "Yu Li Su"

Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with wild-type metastatic colorectal cancer: a nationwide real-world study.

Ching-Wen Huang, Chou-Chen Chen, Shih-Ching Chang, Yu-Yao Chang, Bo-Wen Lin, Hung-Chih Hsu, Yu-Li Su

Am J Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy.

Vadim S Koshkin, Pongwut Danchaivijitr, Woo Kyun Bae, Andrey Semenov, Ozgur Ozyilkan, Yu-Li Su, Masao Tsujihata, Silvia Neciosup Delgado

Eur Urol· April 2025

Social Media Activity not collected for this article yet.

Long-term outcome of radiation therapy for locoregional recurrence of upper tract urothelial carcinoma after nephroureterectomy.

Ho-Hsiang Chang, Hao-Lun Luo, Yu-Li Su, Fu-Min Fang, Chong-Jong Wang

BMC Urol· April 2025

Social Media Activity not collected for this article yet.

Real-world study of cabozantinib treatment of advanced renal cell carcinoma in Taiwan.

Yu-Chieh Tsai, Jian-Ri Li, Kun-Yuan Chiu, Po-Jung Su, Yu-Li Su

J Formos Med Assoc· April 2025

Social Media Activity not collected for this article yet.

Impact of iron-deficiency anemia on short-term outcomes after resection of colorectal cancer liver metastasis: a US National (Nationwide) Inpatient Sample (NIS) analysis.

Ko-Chao Lee, Yu-Li Su, Kuen-Lin Wu, Kung-Chuan Cheng, Ling-Chiao Song

Ann Coloproctol· April 2025

Social Media Activity not collected for this article yet.

Multicenter, international, retrospective study of prognostic factors for Ra223.

Takuya Oishi, Hao-Lun Luo, Yoshiomi Hatayama, Hideo Kawaguchi, Daichi Sasaki, Yu-Li Su

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Combining serum inflammatory markers and clinical factors to predict survival in metastatic urothelial carcinoma patients treated with immune checkpoint inhibitors.

Liang-Yun Cheng, Po-Jung Su, Ming-Chun Kuo, Chang-Ting Lin, Hao-Lun Luo, Chien-Hsu Chen, Harvey Yu-Li Su

Ther Adv Med Oncol· December 2024

Social Media Activity not collected for this article yet.

Outcomes of upfront primary tumor resection in patients with synchronous wild-type metastatic colorectal cancer.

Po-Jung Chen, Chou-Chen Chen, Shih-Ching Chang, Yu-Yao Chang, Bo-Wen Lin, Hung-Chih Hsu, Yu-Li Su

Am J Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Continuing anti-EGFR monoclonal antibody after secondary resection significantly prolongs overall survival for patients with metastatic colorectal cancer who were responsive to first-line anti-EGFR monoclonal antibody plus chemotherapy doublet.

Yao-Yu Hsieh, Yu-Li Su, Feng-Che Kuan, Shu-Chuan Grace Chen, Chia-Lun Chang

Am J Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Outcomes of Robot-Assisted Versus Laparoscopic Surgery for Colorectal Cancer in Adults Aged 75 Years and Older: A Propensity Score-Matched Analysis of the US Nationwide Inpatient Sample.

Kuan-Chih Chung, Kuen-Lin Wu, Yu-Li Su, Kung-Chuan Cheng, Chien-En Tang

Dis Colon Rectum· September 2024

Social Media Activity not collected for this article yet.

Association between Statin Use and Clinical Outcomes in Patients with Metastatic Prostate Cancer: A Propensity Score-weighted Analysis.

Tzu Shuang Chen, Hui Ying Liu, Yin Lun Chang, Yao Chi Chuang, Yen Ta Chen, Yu Li Su

World J Mens Health· July 2024

Social Media Activity not collected for this article yet.

Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial.

Nobuaki Matsubara, Ronald de Wit, Arjun Vasant Balar, Arlene O Siefker-Radtke, Jakub Zolnierek, Yu-Li Su

Eur Urol· March 2024

Social Media Activity not collected for this article yet.

The impact of body mass index on survival endpoints among patients with metastatic urothelial carcinoma undergoing treatment with immune checkpoint inhibitors: A real-world multicenter analysis.

Shih-Yu Huang, Po-Jung Su, Chang-Ting Lin, Ming-Chun Kuo, Yi-Hua Chen, Chien-Hsu Chen, Yu-Li Su

Cancer Med· January 2024

Social Media Activity not collected for this article yet.

Survival benefit of metastasectomy in first-line cetuximab therapy in patients with RAS wild-type metastatic colorectal cancer: a nationwide registry.

Chou-Chen Chen, Shih-Ching Chang, Yu-Yao Chang, Bo-Wen Lin, Hong-Hwa Chen, Hung-Chih Hsu, Yu-Li Su, Hsuan-Yuan Huang

Am J Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Chitinase 3-like-1 Expression in the Microenvironment Is Associated with Neutrophil Infiltration in Bladder Cancer.

Ling-Yi Xiao, Yu-Li Su, Shih-Yu Huang, Yi-Hua Chen, Po-Ren Hsueh

Int J Mol Sci· November 2023

Social Media Activity not collected for this article yet.

Lymph node metastasis and tumor-educated immune tolerance: Potential therapeutic targets against distant metastasis.

Jei-Ming Peng, Yu-Li Su

Biochem Pharmacol· September 2023

Social Media Activity not collected for this article yet.

The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy.

Tsung-Han Tsai, Po-Jung Su, Shih-Yu Huang, Ming-Chun Kuo, Chang-Ting Lin, Chien-Hsu Chen, Yu-Li Su

BMC Cancer· September 2023

Social Media Activity not collected for this article yet.

Efficacy and Safety of a Parenteral Nutrition Program for Patients with Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study.

Yu-Tang Chang, Chou-Chen Chen, Shih-Ching Chang, Yu-Yao Chang, Bo-Wen Lin, Hung-Chih Hsu, Yu-Li Su

Nutrients· June 2023

Social Media Activity not collected for this article yet.

Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process.

Yu-Li Su, Ling-Yi Xiao, Shih-Yu Huang, Chia-Che Wu, Li-Chung Chang

Cells· May 2023

Social Media Activity not collected for this article yet.

The prognostic impact of lymphovascular invasion for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis.

Yin Lun Chang, Yen Ta Chen, Hung Hen Wang, Po Hui Chiang, Yuan Tso Cheng, Yu Li Su, Sung Min Tse

Medicine (Baltimore)· April 2023

Social Media Activity not collected for this article yet.

The impact of sarcopenia on overall survival in patients with pan-RAS wild-type colorectal liver metastasis receiving hepatectomy.

Yao-Ren Yang, Chung-Sheng Shi, Sheng-Wei Chang, Yu-Ying Wu, Yu-Li Su

Sci Rep· April 2023

Social Media Activity not collected for this article yet.

VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma.

Hao-Lun Luo, Yin-Lun Chang, Hui-Ying Liu, Yen-Ting Wu, Ming-Tse Sung, Yu-Li Su

Int J Mol Sci· April 2023

Social Media Activity not collected for this article yet.

Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.

Hung-Kai Chen, Po-Jung Su, Yan-Lin Wang, Kai-Cheng Chang, Yu-Li Su, Chia-Hsun Hsieh, Ying-Hsu Chang

Int J Cancer· March 2023

Social Media Activity not collected for this article yet.

Treatment outcomes with radium-223 in docetaxel-naïve versus docetaxel-treated metastatic castration-resistant prostate cancer patients: Real-world evidence from Taiwan.

Ping-Chia Chiang, Po-Hui Chiang, I-Hsuan Alan Chen, Yen-Ta Chen, Hung-Jen Wang, Chien-Hsu Chen, Yu-Li Su

Medicine (Baltimore)· February 2023

Social Media Activity not collected for this article yet.

Cupping Therapy as an Adjunctive Therapy for Side Effects of Colorectal Cancer Treatment: A Prospective Observational Study.

Yan-Wen Liu, Yu-Li Su, Chia-Lo Chang, Ming-Yen Tsai

J Chiropr Med· December 2022

Social Media Activity not collected for this article yet.

Socials: